ROLE OF ANTICONVULSANT THERAPEUTIC DRUG MONITORING IN IMPROVING CLINICAL OUTCOMES, THE EXAMPLE OF 12 ADULT EPILEPSIES

  • Ana Ranković Radiology Diagnostic Service, The Clinical Center Kragujevac, Serbia
  • Jasmina Milovanović University of Kragujevac, Medical faculty
  • Snežana V Janković University of Kragujevac, Faculty of Medical Sciences
  • Natalija Todorović Clinical Center in Kragujevac, Department of Neurology
  • Nemanja Rančić University of Kragujevac, Medical Faculty
  • Nikola Jestrović Merck Sharp & Dohme Idea Inc. AG Beograd, Serbia
  • Iztok Grabnar Univerzitet u Ljubljani, Farmaceutski fakultet, Slovenija
  • Slobodan Janković University in Kragujevac, Faculty of medicine
  • Mihajlo Jakovljević Univerzitet u Kragujevcu, Fakultet medicinskih nauka
DOI: https://doi.org/10.5937/sjecr13-1673
Keywords: Quality of life, Adverse events, Pharmacokinetics, Seizure control, Clinical outcomes, Drug Monitoring, Anticonvulsants,

Abstract


According to offficial Instructions for authors abstract is not needed in Letter to the Editor type of contribution.

Author Biography

Mihajlo Jakovljević, Univerzitet u Kragujevcu, Fakultet medicinskih nauka
Mihajlo B. Jakovljevic, MD, PhD                             
Assistant Professor                                                
Department of Pharmacology and Toxicology         
University of Kragujevac School of Medicine           
Svetozara Markovica 69                                        
34000 Kragujevac, Serbia
Tel: ++381 34 306 800 ext 223
Fax: ++ 381 34 306 800
Published
2012/07/06
Issue
Vol. 13 No. 2 (2012): Serbian Journal of Experimental and Clinical Research
Section
Letter to the Editor
Serbian Journal of Experimental and Clinical Research copyright covers the exclusive and unlimited rights to reproduce and distribute the articles published in this journal in any form of reproduction (printing, electronic media or any other form); it also covers translation rights for all languages and countries.